drug

bexobrutideg

1 story · latest Jul 9, 2026

Status: Investigational
Code: NX-5948
Trials: 5 registered trials in coverage

Relationships

Developed by Nurix Therapeutics, Inc.

Timeline

Nurix strikes $2.3 billion Roche pact for BTK degrader bexobrutideg

Jul 9Quarterly updatebexobrutideg Nurix Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.